These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8691183

  • 21. [Postmenopausal hormone replacement therapy and cancer of the female genitalia and breast].
    Burger CW, Koomen I, Peters NA, van Leeuwen FE, Kenemans P.
    Ned Tijdschr Geneeskd; 1997 Feb 22; 141(8):368-72. PubMed ID: 9157296
    [Abstract] [Full Text] [Related]

  • 22. [Hormone replacement therapy and cardiovascular risk].
    Maffei S, De Caterina R.
    G Ital Cardiol; 1996 Aug 22; 26(8):899-940. PubMed ID: 9005173
    [Abstract] [Full Text] [Related]

  • 23. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG.
    CMAJ; 1996 Oct 01; 155(7):929-34. PubMed ID: 8837542
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Controversy between estrogen replacement therapy and risk of breast cancer in menopause].
    Zárate A.
    Gac Med Mex; 2002 Oct 01; 138(1):105-7. PubMed ID: 11885123
    [Abstract] [Full Text] [Related]

  • 26. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA, Blake JM, Crosignani PG.
    Hum Reprod Update; 2005 Oct 01; 11(6):545-60. PubMed ID: 16150813
    [Abstract] [Full Text] [Related]

  • 27. Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer.
    Alvarez-Vasquez RB, Axelrod D, Frenkel K, Newman MC, Sepkovic DW, Bradlow HL, Zumoff B.
    Horm Metab Res; 2003 Jun 01; 35(6):358-61. PubMed ID: 12920658
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H.
    Maturitas; 2005 May 16; 51(1):83-97. PubMed ID: 15883113
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Postmenopausal hormone therapy: have HERS2 and WHI given us any new information?
    Fylstra DL.
    J S C Med Assoc; 2002 Dec 16; 98(8):299-304. PubMed ID: 12532655
    [Abstract] [Full Text] [Related]

  • 33. Hormone replacement therapy: dilemmas in 2002.
    Moore A.
    Trans Am Clin Climatol Assoc; 2003 Dec 16; 114():233-8; discussion 238-40. PubMed ID: 12813923
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP.
    Curr Womens Health Rep; 2003 Jun 16; 3(3):181-6. PubMed ID: 12734027
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Postmenopausal hormone replacement therapy: endometrial and breast effects.
    Yeh IT.
    Adv Anat Pathol; 2007 Jan 16; 14(1):17-24. PubMed ID: 17198307
    [Abstract] [Full Text] [Related]

  • 38. [Last word on hormone replacement and breast cancer?].
    Rookus MA, van Leeuwen FE, Hamerlynck JV.
    Ned Tijdschr Geneeskd; 1998 Jan 17; 142(3):111-3. PubMed ID: 9557006
    [Abstract] [Full Text] [Related]

  • 39. The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy.
    Trinh XB, Peeters F, Tjalma WA.
    Eur J Obstet Gynecol Reprod Biol; 2006 Feb 01; 124(2):250-3. PubMed ID: 16144734
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.